Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +14.17%
#3 Biconomy Biconomy +13.82%
#4 Fabric Protocol Fabric Protocol +7.62%
#5 Collect on Fanable Collect on Fanable +5.29%
#6 Cap Cap +4.99%
#7 MYX Finance MYX Finance +3.69%
#8 Dual Dual +3.59%
#9 Catizen Catizen +3.50%
#10 Figure Heloc Figure Heloc +3.49%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Roquefort Therapeutics plc Roquefort Therapeutics plc

Roquefort Therapeutics plc

ROQ
Rang in Aktien #37956
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its... Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Aktienkurs
$0.10205262
Zuletzt synchronisiert: 2026-04-23
Marktkapitalisierung
$1.32M
Veränderung (1 Tag)
5.19%
Veränderung (1 Jahr)
-54.38%
Land
GB
Handel Roquefort Therapeutics plc (ROQ)

Kategorie

Healthcare
Kursverlauf für Roquefort Therapeutics plc (ROQ)
Höchster Schlusskurs: $0.11 am 2026-04-01

Niedrigster Schlusskurs: $1.11 am 2021-03-01
Kursverlauf der Aktie von Roquefort Therapeutics plc von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 5.75%
2025 -65.57%
2024 -41.05%
2023 6.79%
2022 -46.27%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE